Education
About Us
Working with TipRanks
Follow Us
Divi's Laboratories Limited (IN:DIVISLAB)
:DIVISLAB
Total Valuation
Divi's Laboratories Limited has a market cap or net worth of ₹1.60T. The enterprise value is ₹1.58T.
Market Cap₹1.60T
Enterprise Value₹1.58T
Share Statistics
Divi's Laboratories Limited has 265,468,570 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding265,468,570
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Divi's Laboratories Limited’s return on equity (ROE) is 0.15 and return on invested capital (ROIC) is 12.79%.
Return on Equity (ROE)0.15
Return on Assets (ROA)0.13
Return on Invested Capital (ROIC)12.79%
Return on Capital Employed (ROCE)0.17
Revenue Per Employee9.61M
Profits Per Employee2.25M
Employee Count9,741
Asset Turnover0.55
Inventory Turnover1.86
Valuation Ratios
The current PE Ratio of Divi's Laboratories Limited is 64.1. Divi's Laboratories Limited’s PEG ratio is 1.82.
PE Ratio64.1
PS Ratio15.74
PB Ratio9.84
Price to Fair Value9.84
Price to FCF290.01
Price to Operating Cash Flow0.00
PEG Ratio1.82
Income Statement
In the last 12 months, Divi's Laboratories Limited had revenue of 93.58B and earned 21.91B in profits. Earnings per share was 82.53.
Revenue93.58B
Gross Profit31.91B
Operating Income26.38B
Pretax Income29.16B
Net Income21.91B
EBITDA33.21B
Earnings Per Share (EPS)82.53
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
Divi's Laboratories Limited pays an annual dividend of ₹30, resulting in a dividend yield of 0.46%
Dividend Per Share₹30
Dividend Yield0.46%
Payout Ratio32.06%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.92
52-Week Price Change4.34%
50-Day Moving Average6.41K
200-Day Moving Average6.34K
Relative Strength Index (RSI)34.26
Average Volume (3m)6.36K
Important Dates
Divi's Laboratories Limited upcoming earnings date is Feb 5, 2026, TBA (Confirmed).
Last Earnings DateNov 7, 2025
Next Earnings DateFeb 5, 2026
Ex-Dividend Date―
Financial Position
Divi's Laboratories Limited as a current ratio of 6.94, with Debt / Equity ratio of 0.58%
Current Ratio6.94
Quick Ratio4.65
Debt to Market Cap<0.01
Net Debt to EBITDA-0.13
Interest Coverage Ratio879.33
Taxes
In the past 12 months, Divi's Laboratories Limited has paid 7.25B in taxes.
Income Tax7.25B
Effective Tax Rate0.25
Enterprise Valuation
Divi's Laboratories Limited EV to EBITDA ratio is 44.23, with an EV/FCF ratio of 289.17.
EV to Sales15.70
EV to EBITDA44.23
EV to Free Cash Flow289.17
EV to Operating Cash Flow75.49
Balance Sheet
Divi's Laboratories Limited has ₹35.27B in cash and marketable securities with ₹0.00 in debt, giving a net cash position of ₹35.27B billion.
Cash & Marketable Securities₹35.27B
Total Debt₹0.00
Net Cash₹35.27B
Net Cash Per Share₹132.86
Tangible Book Value Per Share₹563.72
Margins
Gross margin is 51.63%, with operating margin of 28.19%, and net profit margin of 23.41%.
Gross Margin51.63%
Operating Margin28.19%
Pretax Margin31.16%
Net Profit Margin23.41%
EBITDA Margin35.49%
EBIT Margin31.19%
Analyst Forecast
The average price target for Divi's Laboratories Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast16.43%
EPS Growth Forecast35.35%